Irsko - angličtina - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - ephedrine hydrochloride - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - ephedrine

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 7.9 microgram/ml (equivalent: fentanyl, qty 5 microgram/ml); bupivacaine hydrochloride, quantity: 1.25 mg/ml; bupivacaine hydrochloride monohydrate, quantity: 1.32 mg/ml (equivalent: bupivacaine hydrochloride, qty 1.25 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - marcain 0.125% with fentanyl 1000 microgram/200ml is intended for post-operative or obstetric epidural analgesia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - fentanyl citrate 3.14 µg/ml equivalent to 2 µg/ml fentanyl;  ; ropivacaine hydrochloride monohydrate 2.12 mg/ml equivalent to 2 mg/ml ropivacaine hydrochloride anhydrous;   - solution for infusion - active: fentanyl citrate 3.14 µg/ml equivalent to 2 µg/ml fentanyl   ropivacaine hydrochloride monohydrate 2.12 mg/ml equivalent to 2 mg/ml ropivacaine hydrochloride anhydrous   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

astrazeneca limited - fentanyl citrate 6.28 µg/ml equivalent to 4 µg/ml fentanyl; ropivacaine hydrochloride monohydrate 2.12 mg/ml equivalent to 2 mg/ml ropivacaine hydrochloride anhydrous - solution for infusion - active: fentanyl citrate 6.28 µg/ml equivalent to 4 µg/ml fentanyl ropivacaine hydrochloride monohydrate 2.12 mg/ml equivalent to 2 mg/ml ropivacaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection

Kanada - angličtina - Health Canada

sandoz canada incorporated - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Kanada - angličtina - Health Canada

omega laboratories limited - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 7.86 microgram/ml (equivalent: fentanyl, qty 5 microgram/ml); bupivacaine hydrochloride, quantity: 1.25 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 1.32 microgram/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indiactions as at 18 april 2000: marcain 0.125% with fentanyl 5 micrograms/ml is intended for post-operative or obstetric epidural analgesia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - ephedrine hydrochloride 3 mg/ml - solution for injection - 30 mg/10ml - active: ephedrine hydrochloride 3 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium citrate sodium hydroxide water for injection - indicated for the treatment of hypotension secondary to spinal anaesthesia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg;  ;  ;   - modified release tablet - 150 mg - active: venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225 mg;  ;  ;   - modified release tablet - 225 mg - active: venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.